[HTML][HTML] COVID-19 in early 2021: current status and looking forward

C Wang, Z Wang, G Wang, JYN Lau… - Signal Transduction and …, 2021 - nature.com
Since the first description of a coronavirus-related pneumonia outbreak in December 2019,
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …

Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …

Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension

G Iaccarino, G Grassi, C Borghi, C Ferri, M Salvetti… - …, 2020 - Am Heart Assoc
Several factors have been proposed to explain the high death rate of the coronavirus
disease 2019 (COVID-19) outbreak, including hypertension and hypertension-related …

Obesity is a risk factor for developing critical condition in COVID‐19 patients: a systematic review and meta‐analysis

M Földi, N Farkas, S Kiss, N Zádori, S Váncsa… - Obesity …, 2020 - Wiley Online Library
The disease course of COVID‐19 varies from asymptomatic infection to critical condition
leading to mortality. Identification of prognostic factors is important for prevention and early …

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

JB Cohen, TC Hanff, P William, N Sweitzer… - The lancet respiratory …, 2021 - thelancet.com
Background Biological considerations suggest that renin–angiotensin system inhibitors
might influence the severity of COVID-19. We aimed to evaluate whether continuing versus …

Endocrine and metabolic aspects of the COVID-19 pandemic

M Marazuela, A Giustina, M Puig-Domingo - Reviews in Endocrine and …, 2020 - Springer
COVID-19 infection has tremendously impacted our daily clinical practice as well as our
social living organization. Virtually all organs and biological systems suffer from this new …

[HTML][HTML] Evidence regarding vitamin D and risk of COVID-19 and its severity

J Mercola, WB Grant, CL Wagner - Nutrients, 2020 - mdpi.com
Vitamin D deficiency co-exists in patients with COVID-19. At this time, dark skin color,
increased age, the presence of pre-existing illnesses and vitamin D deficiency are features …

Role of Hypertension on the Severity of COVID-19: A Review

M Peng, J He, Y Xue, X Yang, S Liu… - Journal of …, 2021 - journals.lww.com
The novel coronavirus disease (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. The …

The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19

F Silvagno, A Vernone, GP Pescarmona - Antioxidants, 2020 - mdpi.com
The novel COVID-19 pandemic is affecting the world's population differently: mostly in the
presence of conditions such as aging, diabetes and hypertension the virus triggers a lethal …

Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target-a perspective

T Magrone, M Magrone, E Jirillo - Endocrine, Metabolic & …, 2020 - ingentaconnect.com
Coronaviruses (CoVs) possess an enveloped, single, positive-stranded RNA genome that
encodes for four membrane proteins, namely spike (S), envelope (E), membrane (M) and …